7/28/2023 0 Comments Timi score populationThis is particularly important for lower-middle-income countries, which are increasingly affected by cardiovascular disease epidemic and encompass different genetics and lifestyle. Hence, the development of the TIMI risk score originated from developed countries, with limited data evaluating the effectiveness in developing countries. The TIMI score was established as one of the most commonly utilized risk assessment models in the chest pain units to warrant further workup. Patients presenting with Unstable Angina (UA) or NSTEMI that fit score 3 or more on the TIMI model are mostly recommended to undergo early invasive management with cardiac angiography and revascularization if necessary ( 9). There are seven components used in the calculation of the TIMI score. The TIMI (Thrombolysis in Myocardial Infarction) research group has introduced a specific model, the TIMI risk score assessment tool, which has been found to be predictive of the severity of vascular diseases and the potential of coronary circulation involvement in chest pain patients ( 8). Nonetheless, electrocardiogram (ECG), as the most readily available diagnostic tool in chest pain units, is not adequately helpful in decision making( 7). Choosing the best treatment in the initial stages following quick diagnosis is of great importance in improving the outcome. Several randomized clinical trials performed in the past two decades have established that immediate and complete restoration of flow in the occluded artery decreases infarct size, improves survival rates, and preserves left ventricular (LV) function ( 5, 6). Each year, three million people experience ST-segment elevation MI (STEMI) and also non-ST-segment elevation MI (NSTEMI) was estimated to occur in about four million ( 4). Myocardial infarction (MI) is known as the most severe presentation of CAD and CAD accounts for 30% of all mortalities ( 3). Despite recent developments, coronary artery disease (CAD) remains the leading cause of death across the world. Advancements of cardiac care units and revascularization methods, as well as the developments in pharmacotherapy, have led to improved patient outcomes after acute coronary syndrome (ACS) ( 1, 2).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |